This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Open AccessArticle
Pharmacokinetics and Tissue Distribution of Fluorescently Labeled Neoagarotetraose in Mice
by
Nan Wu
Nan Wu
,
Chaocheng Wu
Chaocheng Wu ,
Yating Du
Yating Du
,
Zhuhua Chan
Zhuhua Chan and
Runying Zeng
Runying Zeng *
Technology Innovation Center for Exploitation of Marine Biological Resources, Third Institute of Oceanography, Ministry of Natural Resources, Xiamen 361005, China
*
Author to whom correspondence should be addressed.
Pharmaceutics 2026, 18(6), 725; https://doi.org/10.3390/pharmaceutics18060725 (registering DOI)
Submission received: 28 April 2026
/
Revised: 3 June 2026
/
Accepted: 9 June 2026
/
Published: 11 June 2026
Abstract
Background/Objectives: Neoagarotetraose (NA4), a marine-derived tetrasaccharide, holds promise as an anti-inflammatory and antioxidant agent; however, its oral bioavailability and systemic exposure mechanisms require elucidation. Methods: This study characterizes the biopharmaceutical profile of NA4 after oral and intravenous administration using a validated near-infrared fluorescence method based on covalent conjugation with Cy7. Results: Following oral gavage (200 mg/kg), NA4-Cy7 was rapidly absorbed (Tmax: 1.0 h; Cmax: 35.6 mg/L), with prolonged systemic exposure (mean residence time: 13.1 h) and an elimination half-life of 8.9 h. Intravenous administration (25 mg/kg) revealed a low volume of distribution at steady state (Vss: 0.0132 L/kg) and a shorter MRT (4.3 h). Tissue distribution at 24 h showed preferential accumulation in the kidney, liver, and lung, with direct visualization of intact NA4 crossing the intestinal epithelium. Conclusions: These findings demonstrate that fluorescently labeled NA4-Cy7 can cross the intestinal epithelial barrier and reach systemic circulation, supporting its potential as an orally active agent with organ-specific targeting properties.
Share and Cite
MDPI and ACS Style
Wu, N.; Wu, C.; Du, Y.; Chan, Z.; Zeng, R.
Pharmacokinetics and Tissue Distribution of Fluorescently Labeled Neoagarotetraose in Mice. Pharmaceutics 2026, 18, 725.
https://doi.org/10.3390/pharmaceutics18060725
AMA Style
Wu N, Wu C, Du Y, Chan Z, Zeng R.
Pharmacokinetics and Tissue Distribution of Fluorescently Labeled Neoagarotetraose in Mice. Pharmaceutics. 2026; 18(6):725.
https://doi.org/10.3390/pharmaceutics18060725
Chicago/Turabian Style
Wu, Nan, Chaocheng Wu, Yating Du, Zhuhua Chan, and Runying Zeng.
2026. "Pharmacokinetics and Tissue Distribution of Fluorescently Labeled Neoagarotetraose in Mice" Pharmaceutics 18, no. 6: 725.
https://doi.org/10.3390/pharmaceutics18060725
APA Style
Wu, N., Wu, C., Du, Y., Chan, Z., & Zeng, R.
(2026). Pharmacokinetics and Tissue Distribution of Fluorescently Labeled Neoagarotetraose in Mice. Pharmaceutics, 18(6), 725.
https://doi.org/10.3390/pharmaceutics18060725
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details
here.
Article Metrics
Article Access Statistics
For more information on the journal statistics, click
here.
Multiple requests from the same IP address are counted as one view.